@ARTICLE{
author={Sacca Francesco,Barnett Carolina,Vu Tuan,Peric Stojan Z,Phillips Glenn A,Zhao Sihui,Qi Cynthia Z,Gelinas Deborah,Chiroli Silvia,Verschuuren Jan JGM},
year={2023},
title={Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT)},
journal={JOURNAL OF NEUROLOGY},
volume={270},
number={4},
pages={2096-2105},
document_type={Article},
} 

@ARTICLE{
author={Howard James,Bril Vera,Vu Tuan,Karam Chafic,Peric Stojan Z,Murai Hiroyuki,Guglietta Antonio,Ulrichts Peter,Vangeneugden Tony,Utsugisawa Kimiaki,Verschuuren Jan JGM,Mantegazza Renato},
year={2021},
title={Efficacy, Safety, and Tolerability of Efgartigimod in Patients With Generalized Myasthenia Gravis: Analysis of the Phase 3 ADAPT Study},
journal={NEUROLOGY},
volume={96},
number={15},
pages={-},
document_type={Meeting Abstract},
}